ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NVRO Nevro Corp

5.72
0.00 (0.00%)
Pre Market
Last Updated: 10:09:46
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nevro Corp NYSE:NVRO NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 5.72 4 10:09:46

Kuehn Law Encourages NVRO, SLRN, TGI, and PTMN Investors to Contact Law Firm

10/02/2025 2:11pm

PR Newswire (US)


Nevro (NYSE:NVRO)
Historical Stock Chart


From Jan 2025 to Feb 2025

Click Here for more Nevro Charts.

NEW YORK, Feb. 10, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.  Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. 

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

  • Nevro Corp. (NYSE: NVRO) Click to Take Action

Nevro Corp. has entered into a definitive agreement Globus Medical for $5.85 per share. Both boards have unanimously approved the deal, expected to close in late Q2 2025, pending shareholder and regulatory approval.

  • ACELYRIN, INC. (NASDAQ: SLRN) Click to Take Action

ACELYRIN, INC. has agreed to be acquired by Alumis Inc. for 0.4274 shares of Alumis common stock for each share of ACELYRIN common stock. Upon closing, Alumis stockholders will own approximately 55% and Acelyrin stockholders 45% of the combined company, on a fully diluted basis.

  • Triumph Group, Inc. (NYSE: TGI) Click to Take Action

Triumph Group, Inc. has entered into a definitive agreement with Warburg Pincus and Berkshire Partners for $26.00 per share in cash. Upon completion of the transaction, Triumph will become a privately held company under joint control of the two equity firms.

  • Portman Ridge Finance Corporation (NASDAQ: PTMN) Click to Take Action

Portman Ridge Finance Corporation has agreed to be acquired by Logan Ridge Finance Corporation. Under the proposed agreement, Portman Ridge will remain the surviving public entity and continue trading on Nasdaq under the symbol "PTMN."

Why Your Participation Matters:

SHAREHOLDER CASES: ADDRESSING THE INJUSTICE

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact the Firm at moon@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients.  Shareholders are advised to act promptly, as legal rights may be time-sensitive.  For additional information, please visit Merger Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Moon K. Young                                                                 
Chief of Operations
Kuehn Law, PLLC
53 Hill Street, Suite 605
Southampton, NY 11968
moon@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-nvro-slrn-tgi-and-ptmn-investors-to-contact-law-firm-302372263.html

SOURCE Kuehn Law, PLLC

Copyright 2025 PR Newswire

1 Year Nevro Chart

1 Year Nevro Chart

1 Month Nevro Chart

1 Month Nevro Chart

Your Recent History

Delayed Upgrade Clock